ProNAi Therapeutics Lands $310,000 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=597ff1f9-edda-4f5b-80e8-22a113793ba2&Preview=1 - Date
4/4/2012 - Company Name
ProNAi Therapeutics - Mailing Address
2725 South Industrial Hwy Ann Arbor, MI 48104 - Company Description
ProNAi Therapeutics, Inc. is an emerging biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi, to advance a next generation of therapies for patients with cancer and other complex genetic diseases. - Website
http://www.pronai.com - Transaction Type
Debt - Transaction Amount
$310,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
